Old Diseases, New Threats: Are You Still Protected – and What Will Your Health Plan Cover?

With infectious diseases such as measles on the rise, many Americans are wondering what they can do to protect themselves and loved ones against illness. CHIR’s Leila Sullivan breaks down what vaccines, boosters and titers tests your insurance is and is not required to cover under current federal law.
March Research Roundup: What We’re Reading
In Latest Policy Change for DACA Recipients, Trump Administration Proposes Elimination of Marketplace Insurance Eligibility

In recently proposed regulatory changes to marketplace coverage, the Trump Administration intends to strip Deferred Action for Childhood Arrivals (DACA) recipients of eligibility for marketplace coverage. This proposal represents the latest twist in the roller coaster of policy changes and litigation DACA recipients have endured.
State Flexibility To Add Adult Dental Care to Essential Health Benefits: An Update on State Action
Federal Rule Gives Regulators Enhanced Tools to Ensure Equitable Access to Behavioral Health Care

Last fall, the Biden Administration finalized a rule updating standards for the Mental Health Parity and Addiction Equity Act (MHPAEA). In their latest piece for the Commonwealth Fund, CHIR’s JoAnn Volk and Billy Dering discuss the new requirements for use of “non-quantitative treatment limits” that impose significant barriers to behavioral health treatment.
CHIR Welcomes New Faculty and Staff
We are delighted to welcome three new members to the CHIR team: Karen Handorf, Julia Burleson, and Amanda Concepcion.
New Executive Order Outlines Next Steps For Health Care Price Transparency

In February, the Trump administration issued an executive order outlining steps for federal agencies to promote healthcare price transparency for patients, employers, and policymakers. In her latest piece for Health Affairs, Stacey Pogue explores how this executive order could improve areas where healthcare price transparency has historically faced challenges.